Safety of bevacizumab in patients with malignant gliomas: a systematic review View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-01

AUTHORS

G. Simonetti, E. Trevisan, A. Silvani, P. Gaviani, A. Botturi, E. Lamperti, D. Beecher, L. Bertero, C. Bosa, A. Salmaggi

ABSTRACT

Angiogenesis has recently become a major target for the development of new antineoplastic drugs. The most serious adverse events linked to angiogenesis inhibitors are venous or arterial thromboembolism and haemorrhage. Thus, there is need to define with more certainty the impact of these new drugs in terms of adverse effects in neurological patients. The aim of the study is to assess the risk of venous thromboembolism (VTE) and bleeding in patients with malignant gliomas treated with bevacizumab with or without concomitant anticoagulant therapy. A review of published literature was performed in Medline, from which 476 records were identified. A total of 27 full-text articles, including retrospective analyses, retrospective reviews, and open label trials, were assessed for eligibility. The investigated drugs included bevacizumab alone, bevacizumab plus chemotherapy with/without concomitant radiation therapy; only two articles dealt with bevacizumab in association with anticoagulant treatment. A total of 2,208 patients with malignant gliomas, were identified and included in the analysis. From data it appears that patients receiving bevacizumab had a major risk of developing VTE that increased when bevacizumab is associated with radio-chemotherapy (4.27 vs 7.46 %). Regarding bleeding, data showed that patients treated with anticoagulant had a significantly increased risk of severe central nervous system (CNS) bleeding compared to patients not receiving anticoagulant therapy (0.6 vs 8.2 %). The use of bevacizumab combined with chemo-radiotherapy seems to be associated with a higher risk for VTE compared to patients receiving antiangiogenic therapy alone. The associated use of anticoagulants and bevacizumab far increases the risk of developing CNS and non-CNS bleeding higher than grade 3, compared to patients receiving bevacizumab alone. More... »

PAGES

83-89

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10072-013-1583-6

DOI

http://dx.doi.org/10.1007/s10072-013-1583-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1047201631

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24281944


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiogenesis Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bevacizumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Venous Thromboembolism", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Istituto Neurologico Carlo Besta", 
          "id": "https://www.grid.ac/institutes/grid.417894.7", 
          "name": [
            "Department of Neurooncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Simonetti", 
        "givenName": "G.", 
        "id": "sg:person.01252270246.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252270246.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliero Universitaria San Giovanni Battista", 
          "id": "https://www.grid.ac/institutes/grid.413005.3", 
          "name": [
            "Division of Neuro-oncology, Department of Neuroscience, University and San Giovanni Battista Hospital, Turin, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Trevisan", 
        "givenName": "E.", 
        "id": "sg:person.01210506657.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210506657.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Neurologico Carlo Besta", 
          "id": "https://www.grid.ac/institutes/grid.417894.7", 
          "name": [
            "Department of Neurooncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Silvani", 
        "givenName": "A.", 
        "id": "sg:person.01337217237.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337217237.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Neurologico Carlo Besta", 
          "id": "https://www.grid.ac/institutes/grid.417894.7", 
          "name": [
            "Department of Neurooncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gaviani", 
        "givenName": "P.", 
        "id": "sg:person.01265330306.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265330306.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Neurologico Carlo Besta", 
          "id": "https://www.grid.ac/institutes/grid.417894.7", 
          "name": [
            "Department of Neurooncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Botturi", 
        "givenName": "A.", 
        "id": "sg:person.01266121043.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266121043.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Neurologico Carlo Besta", 
          "id": "https://www.grid.ac/institutes/grid.417894.7", 
          "name": [
            "Department of Neurooncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lamperti", 
        "givenName": "E.", 
        "id": "sg:person.01204520207.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204520207.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Neurologico Carlo Besta", 
          "id": "https://www.grid.ac/institutes/grid.417894.7", 
          "name": [
            "Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous, System Review Group, Unit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beecher", 
        "givenName": "D.", 
        "id": "sg:person.0576721171.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576721171.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliero Universitaria San Giovanni Battista", 
          "id": "https://www.grid.ac/institutes/grid.413005.3", 
          "name": [
            "Division of Neuro-oncology, Department of Neuroscience, University and San Giovanni Battista Hospital, Turin, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bertero", 
        "givenName": "L.", 
        "id": "sg:person.01141770554.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141770554.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliero Universitaria San Giovanni Battista", 
          "id": "https://www.grid.ac/institutes/grid.413005.3", 
          "name": [
            "Division of Neuro-oncology, Department of Neuroscience, University and San Giovanni Battista Hospital, Turin, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bosa", 
        "givenName": "C.", 
        "id": "sg:person.01256217154.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256217154.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Neurologico Carlo Besta", 
          "id": "https://www.grid.ac/institutes/grid.417894.7", 
          "name": [
            "Department of Neurooncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salmaggi", 
        "givenName": "A.", 
        "id": "sg:person.0614374604.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614374604.44"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ccr.2006.11.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000989893"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-005-9097-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001104504", 
          "https://doi.org/10.1007/s11060-005-9097-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-005-9097-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001104504", 
          "https://doi.org/10.1007/s11060-005-9097-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2010-0105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001559376"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(09)70025-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002463620"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.166.4.458", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003211102"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23401", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003264880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/nop073", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003769500"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/nop073", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003769500"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-2309", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004441322"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-008-9599-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004532009", 
          "https://doi.org/10.1007/s11060-008-9599-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00177615", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005617755", 
          "https://doi.org/10.1007/bf00177615"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/0284186x.2011.572913", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006425289"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000314980", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008619638"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25462", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009168434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00005792-199909000-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010057240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00005792-199909000-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010057240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1586/14737140.4.2.303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010214744"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jocn.2009.12.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012060047"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/nor223", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013332503"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-008-9718-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014358667", 
          "https://doi.org/10.1007/s11060-008-9718-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.30.2729", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017963788"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2007.11.068", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018476686"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdp591", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019574105"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-11-0120", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019815454"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(20000801)89:3<640::aid-cncr20>3.0.co;2-e", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021056940"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2010.08.058", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024642299"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1227/01.neu.0000370918.51053.bc", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025819952"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.26188", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028514124"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/02841860802537924", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033303184"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.critrevonc.2006.01.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034298471"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12325-011-0007-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037365997", 
          "https://doi.org/10.1007/s12325-011-0007-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2010.09.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039009019"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.19.8721", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042965400"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.24179", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045011263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2008.656", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048505634"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.22.0616", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048915750"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-011-0579-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049920194", 
          "https://doi.org/10.1007/s11060-011-0579-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.22.3271", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050418707"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-011-0642-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051876399", 
          "https://doi.org/10.1007/s11060-011-0642-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01403001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052399274", 
          "https://doi.org/10.1007/bf01403001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01403001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052399274", 
          "https://doi.org/10.1007/bf01403001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.disamonth.2005.03.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052672038"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.99.046", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064204075"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064350042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064350042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064350042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181a413be", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064354319"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181a413be", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064354319"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181a413be", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064354319"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1215/15228517-2008-009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064414329"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.2007.106.4.601", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071102269"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.2007.106.4.601", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071102269"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.2007.106.4.601", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071102269"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/nop063", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078148309"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/noq099", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078202685"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-01", 
    "datePublishedReg": "2014-01-01", 
    "description": "Angiogenesis has recently become a major target for the development of new antineoplastic drugs. The most serious adverse events linked to angiogenesis inhibitors are venous or arterial thromboembolism and haemorrhage. Thus, there is need to define with more certainty the impact of these new drugs in terms of adverse effects in neurological patients. The aim of the study is to assess the risk of venous thromboembolism (VTE) and bleeding in patients with malignant gliomas treated with bevacizumab with or without concomitant anticoagulant therapy. A review of published literature was performed in Medline, from which 476 records were identified. A total of 27 full-text articles, including retrospective analyses, retrospective reviews, and open label trials, were assessed for eligibility. The investigated drugs included bevacizumab alone, bevacizumab plus chemotherapy with/without concomitant radiation therapy; only two articles dealt with bevacizumab in association with anticoagulant treatment. A total of 2,208 patients with malignant gliomas, were identified and included in the analysis. From data it appears that patients receiving bevacizumab had a major risk of developing VTE that increased when bevacizumab is associated with radio-chemotherapy (4.27 vs 7.46 %). Regarding bleeding, data showed that patients treated with anticoagulant had a significantly increased risk of severe central nervous system (CNS) bleeding compared to patients not receiving anticoagulant therapy (0.6 vs 8.2 %). The use of bevacizumab combined with chemo-radiotherapy seems to be associated with a higher risk for VTE compared to patients receiving antiangiogenic therapy alone. The associated use of anticoagulants and bevacizumab far increases the risk of developing CNS and non-CNS bleeding higher than grade 3, compared to patients receiving bevacizumab alone.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10072-013-1583-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1294956", 
        "issn": [
          "1590-1874", 
          "1126-5442"
        ], 
        "name": "Neurological Sciences", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "35"
      }
    ], 
    "name": "Safety of bevacizumab in patients with malignant gliomas: a systematic review", 
    "pagination": "83-89", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e0da6ccbfc730b4f6cb9990c66edadfd609d112647ecff0a100feb712b0229e6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24281944"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100959175"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10072-013-1583-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1047201631"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10072-013-1583-6", 
      "https://app.dimensions.ai/details/publication/pub.1047201631"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T23:29", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8693_00000534.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs10072-013-1583-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10072-013-1583-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10072-013-1583-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10072-013-1583-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10072-013-1583-6'


 

This table displays all metadata directly associated to this object as RDF triples.

314 TRIPLES      21 PREDICATES      83 URIs      29 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10072-013-1583-6 schema:about N30ef94f6b33748a19698fed5a19aac3c
2 N690d9ea6b79142029d2b0a4849cd3b96
3 Nac01097ec6ee4c3c96998b6724a3caae
4 Nb14064f5ccf74974a9febe92451d8b22
5 Nc407bcefceb14eafa1aa2e6150685698
6 Ne8315546f2834a8ea952f7e8afb8e172
7 Nf8531d809b9e48b5aef92b71eeac7eb1
8 Nf92635b433ba4bcf9acad318bac328a4
9 anzsrc-for:11
10 anzsrc-for:1112
11 schema:author N18d0fc44cf0f42ef89b77f7e321086a5
12 schema:citation sg:pub.10.1007/bf00177615
13 sg:pub.10.1007/bf01403001
14 sg:pub.10.1007/s11060-005-9097-6
15 sg:pub.10.1007/s11060-008-9599-0
16 sg:pub.10.1007/s11060-008-9718-y
17 sg:pub.10.1007/s11060-011-0579-4
18 sg:pub.10.1007/s11060-011-0642-1
19 sg:pub.10.1007/s12325-011-0007-3
20 https://doi.org/10.1001/archinte.166.4.458
21 https://doi.org/10.1001/jama.2008.656
22 https://doi.org/10.1002/1097-0142(20000801)89:3<640::aid-cncr20>3.0.co;2-e
23 https://doi.org/10.1002/cncr.23401
24 https://doi.org/10.1002/cncr.24179
25 https://doi.org/10.1002/cncr.25462
26 https://doi.org/10.1002/cncr.26188
27 https://doi.org/10.1016/j.ccr.2006.11.021
28 https://doi.org/10.1016/j.critrevonc.2006.01.004
29 https://doi.org/10.1016/j.disamonth.2005.03.010
30 https://doi.org/10.1016/j.ijrobp.2007.11.068
31 https://doi.org/10.1016/j.ijrobp.2010.08.058
32 https://doi.org/10.1016/j.ijrobp.2010.09.002
33 https://doi.org/10.1016/j.jocn.2009.12.009
34 https://doi.org/10.1016/s1470-2045(09)70025-7
35 https://doi.org/10.1080/02841860802537924
36 https://doi.org/10.1093/annonc/mdp591
37 https://doi.org/10.1093/neuonc/nop063
38 https://doi.org/10.1093/neuonc/nop073
39 https://doi.org/10.1093/neuonc/noq099
40 https://doi.org/10.1093/neuonc/nor223
41 https://doi.org/10.1097/00005792-199909000-00001
42 https://doi.org/10.1158/1078-0432.ccr-06-2309
43 https://doi.org/10.1158/1078-0432.ccr-11-0120
44 https://doi.org/10.1159/000314980
45 https://doi.org/10.1200/jco.2003.99.046
46 https://doi.org/10.1200/jco.2008.19.8721
47 https://doi.org/10.1200/jco.2009.22.0616
48 https://doi.org/10.1200/jco.2009.22.3271
49 https://doi.org/10.1200/jco.2010.30.2729
50 https://doi.org/10.1212/01.wnl.0000304121.57857.38
51 https://doi.org/10.1212/wnl.0b013e3181a413be
52 https://doi.org/10.1215/15228517-2008-009
53 https://doi.org/10.1227/01.neu.0000370918.51053.bc
54 https://doi.org/10.1586/14737140.4.2.303
55 https://doi.org/10.1634/theoncologist.2010-0105
56 https://doi.org/10.3109/0284186x.2011.572913
57 https://doi.org/10.3171/jns.2007.106.4.601
58 schema:datePublished 2014-01
59 schema:datePublishedReg 2014-01-01
60 schema:description Angiogenesis has recently become a major target for the development of new antineoplastic drugs. The most serious adverse events linked to angiogenesis inhibitors are venous or arterial thromboembolism and haemorrhage. Thus, there is need to define with more certainty the impact of these new drugs in terms of adverse effects in neurological patients. The aim of the study is to assess the risk of venous thromboembolism (VTE) and bleeding in patients with malignant gliomas treated with bevacizumab with or without concomitant anticoagulant therapy. A review of published literature was performed in Medline, from which 476 records were identified. A total of 27 full-text articles, including retrospective analyses, retrospective reviews, and open label trials, were assessed for eligibility. The investigated drugs included bevacizumab alone, bevacizumab plus chemotherapy with/without concomitant radiation therapy; only two articles dealt with bevacizumab in association with anticoagulant treatment. A total of 2,208 patients with malignant gliomas, were identified and included in the analysis. From data it appears that patients receiving bevacizumab had a major risk of developing VTE that increased when bevacizumab is associated with radio-chemotherapy (4.27 vs 7.46 %). Regarding bleeding, data showed that patients treated with anticoagulant had a significantly increased risk of severe central nervous system (CNS) bleeding compared to patients not receiving anticoagulant therapy (0.6 vs 8.2 %). The use of bevacizumab combined with chemo-radiotherapy seems to be associated with a higher risk for VTE compared to patients receiving antiangiogenic therapy alone. The associated use of anticoagulants and bevacizumab far increases the risk of developing CNS and non-CNS bleeding higher than grade 3, compared to patients receiving bevacizumab alone.
61 schema:genre research_article
62 schema:inLanguage en
63 schema:isAccessibleForFree false
64 schema:isPartOf N8ca312a328434c448258c4f47fa8bdc4
65 N9b5da8752fdd4831bd62cc9f8220c50d
66 sg:journal.1294956
67 schema:name Safety of bevacizumab in patients with malignant gliomas: a systematic review
68 schema:pagination 83-89
69 schema:productId N25868af39d1c4e28bdcb8413046ab7c2
70 N5daa6315c566438db3d33701c3885df9
71 N696e15cf61fb4069b248a43071c67c35
72 Nbddd092132754c028f0794588c38fbd9
73 Nd5ab7286163d479ba9e5fba7dde1d072
74 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047201631
75 https://doi.org/10.1007/s10072-013-1583-6
76 schema:sdDatePublished 2019-04-10T23:29
77 schema:sdLicense https://scigraph.springernature.com/explorer/license/
78 schema:sdPublisher N4e06922b5295438d9d0f1e6697d3f422
79 schema:url http://link.springer.com/10.1007%2Fs10072-013-1583-6
80 sgo:license sg:explorer/license/
81 sgo:sdDataset articles
82 rdf:type schema:ScholarlyArticle
83 N0d6da43fcf734a09b16419543abe9ba5 rdf:first sg:person.01265330306.32
84 rdf:rest Nb705b4bb43e8427381d0a20f94f3b814
85 N18d0fc44cf0f42ef89b77f7e321086a5 rdf:first sg:person.01252270246.05
86 rdf:rest N9099872daf2c419b9c4818cddcdea008
87 N1bf45d1e0f5c4ae1bf3b080349e54a86 rdf:first sg:person.0576721171.03
88 rdf:rest Nf1932c7519924e3a8ef03e1fccd3667b
89 N25868af39d1c4e28bdcb8413046ab7c2 schema:name nlm_unique_id
90 schema:value 100959175
91 rdf:type schema:PropertyValue
92 N30ef94f6b33748a19698fed5a19aac3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Antibodies, Monoclonal, Humanized
94 rdf:type schema:DefinedTerm
95 N49a1e394050446d8b2ebd17ae403f67f rdf:first sg:person.01337217237.92
96 rdf:rest N0d6da43fcf734a09b16419543abe9ba5
97 N4c3d0cd25a734b83a5abdc4a1b014b40 rdf:first sg:person.01256217154.30
98 rdf:rest N9f418676fcde4d28a5d5fb487696f44a
99 N4e06922b5295438d9d0f1e6697d3f422 schema:name Springer Nature - SN SciGraph project
100 rdf:type schema:Organization
101 N5daa6315c566438db3d33701c3885df9 schema:name dimensions_id
102 schema:value pub.1047201631
103 rdf:type schema:PropertyValue
104 N690d9ea6b79142029d2b0a4849cd3b96 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Glioma
106 rdf:type schema:DefinedTerm
107 N696e15cf61fb4069b248a43071c67c35 schema:name pubmed_id
108 schema:value 24281944
109 rdf:type schema:PropertyValue
110 N6f4b56cf23284b108d3b23ed26672baa rdf:first sg:person.01204520207.23
111 rdf:rest N1bf45d1e0f5c4ae1bf3b080349e54a86
112 N8ca312a328434c448258c4f47fa8bdc4 schema:issueNumber 1
113 rdf:type schema:PublicationIssue
114 N9099872daf2c419b9c4818cddcdea008 rdf:first sg:person.01210506657.44
115 rdf:rest N49a1e394050446d8b2ebd17ae403f67f
116 N9b5da8752fdd4831bd62cc9f8220c50d schema:volumeNumber 35
117 rdf:type schema:PublicationVolume
118 N9f418676fcde4d28a5d5fb487696f44a rdf:first sg:person.0614374604.44
119 rdf:rest rdf:nil
120 Nac01097ec6ee4c3c96998b6724a3caae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Antineoplastic Agents
122 rdf:type schema:DefinedTerm
123 Nb14064f5ccf74974a9febe92451d8b22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Brain Neoplasms
125 rdf:type schema:DefinedTerm
126 Nb705b4bb43e8427381d0a20f94f3b814 rdf:first sg:person.01266121043.19
127 rdf:rest N6f4b56cf23284b108d3b23ed26672baa
128 Nbddd092132754c028f0794588c38fbd9 schema:name readcube_id
129 schema:value e0da6ccbfc730b4f6cb9990c66edadfd609d112647ecff0a100feb712b0229e6
130 rdf:type schema:PropertyValue
131 Nc407bcefceb14eafa1aa2e6150685698 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Humans
133 rdf:type schema:DefinedTerm
134 Nd5ab7286163d479ba9e5fba7dde1d072 schema:name doi
135 schema:value 10.1007/s10072-013-1583-6
136 rdf:type schema:PropertyValue
137 Ne8315546f2834a8ea952f7e8afb8e172 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Angiogenesis Inhibitors
139 rdf:type schema:DefinedTerm
140 Nf1932c7519924e3a8ef03e1fccd3667b rdf:first sg:person.01141770554.98
141 rdf:rest N4c3d0cd25a734b83a5abdc4a1b014b40
142 Nf8531d809b9e48b5aef92b71eeac7eb1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Bevacizumab
144 rdf:type schema:DefinedTerm
145 Nf92635b433ba4bcf9acad318bac328a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Venous Thromboembolism
147 rdf:type schema:DefinedTerm
148 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
149 schema:name Medical and Health Sciences
150 rdf:type schema:DefinedTerm
151 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
152 schema:name Oncology and Carcinogenesis
153 rdf:type schema:DefinedTerm
154 sg:journal.1294956 schema:issn 1126-5442
155 1590-1874
156 schema:name Neurological Sciences
157 rdf:type schema:Periodical
158 sg:person.01141770554.98 schema:affiliation https://www.grid.ac/institutes/grid.413005.3
159 schema:familyName Bertero
160 schema:givenName L.
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141770554.98
162 rdf:type schema:Person
163 sg:person.01204520207.23 schema:affiliation https://www.grid.ac/institutes/grid.417894.7
164 schema:familyName Lamperti
165 schema:givenName E.
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204520207.23
167 rdf:type schema:Person
168 sg:person.01210506657.44 schema:affiliation https://www.grid.ac/institutes/grid.413005.3
169 schema:familyName Trevisan
170 schema:givenName E.
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210506657.44
172 rdf:type schema:Person
173 sg:person.01252270246.05 schema:affiliation https://www.grid.ac/institutes/grid.417894.7
174 schema:familyName Simonetti
175 schema:givenName G.
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252270246.05
177 rdf:type schema:Person
178 sg:person.01256217154.30 schema:affiliation https://www.grid.ac/institutes/grid.413005.3
179 schema:familyName Bosa
180 schema:givenName C.
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256217154.30
182 rdf:type schema:Person
183 sg:person.01265330306.32 schema:affiliation https://www.grid.ac/institutes/grid.417894.7
184 schema:familyName Gaviani
185 schema:givenName P.
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265330306.32
187 rdf:type schema:Person
188 sg:person.01266121043.19 schema:affiliation https://www.grid.ac/institutes/grid.417894.7
189 schema:familyName Botturi
190 schema:givenName A.
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266121043.19
192 rdf:type schema:Person
193 sg:person.01337217237.92 schema:affiliation https://www.grid.ac/institutes/grid.417894.7
194 schema:familyName Silvani
195 schema:givenName A.
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337217237.92
197 rdf:type schema:Person
198 sg:person.0576721171.03 schema:affiliation https://www.grid.ac/institutes/grid.417894.7
199 schema:familyName Beecher
200 schema:givenName D.
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576721171.03
202 rdf:type schema:Person
203 sg:person.0614374604.44 schema:affiliation https://www.grid.ac/institutes/grid.417894.7
204 schema:familyName Salmaggi
205 schema:givenName A.
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614374604.44
207 rdf:type schema:Person
208 sg:pub.10.1007/bf00177615 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005617755
209 https://doi.org/10.1007/bf00177615
210 rdf:type schema:CreativeWork
211 sg:pub.10.1007/bf01403001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052399274
212 https://doi.org/10.1007/bf01403001
213 rdf:type schema:CreativeWork
214 sg:pub.10.1007/s11060-005-9097-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001104504
215 https://doi.org/10.1007/s11060-005-9097-6
216 rdf:type schema:CreativeWork
217 sg:pub.10.1007/s11060-008-9599-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004532009
218 https://doi.org/10.1007/s11060-008-9599-0
219 rdf:type schema:CreativeWork
220 sg:pub.10.1007/s11060-008-9718-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1014358667
221 https://doi.org/10.1007/s11060-008-9718-y
222 rdf:type schema:CreativeWork
223 sg:pub.10.1007/s11060-011-0579-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049920194
224 https://doi.org/10.1007/s11060-011-0579-4
225 rdf:type schema:CreativeWork
226 sg:pub.10.1007/s11060-011-0642-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051876399
227 https://doi.org/10.1007/s11060-011-0642-1
228 rdf:type schema:CreativeWork
229 sg:pub.10.1007/s12325-011-0007-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037365997
230 https://doi.org/10.1007/s12325-011-0007-3
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1001/archinte.166.4.458 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003211102
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1001/jama.2008.656 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048505634
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1002/1097-0142(20000801)89:3<640::aid-cncr20>3.0.co;2-e schema:sameAs https://app.dimensions.ai/details/publication/pub.1021056940
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1002/cncr.23401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003264880
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1002/cncr.24179 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045011263
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1002/cncr.25462 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009168434
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1002/cncr.26188 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028514124
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1016/j.ccr.2006.11.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000989893
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1016/j.critrevonc.2006.01.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034298471
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1016/j.disamonth.2005.03.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052672038
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1016/j.ijrobp.2007.11.068 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018476686
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1016/j.ijrobp.2010.08.058 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024642299
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1016/j.ijrobp.2010.09.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039009019
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1016/j.jocn.2009.12.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012060047
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1016/s1470-2045(09)70025-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002463620
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1080/02841860802537924 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033303184
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1093/annonc/mdp591 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019574105
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1093/neuonc/nop063 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078148309
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1093/neuonc/nop073 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003769500
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1093/neuonc/noq099 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078202685
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1093/neuonc/nor223 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013332503
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1097/00005792-199909000-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010057240
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1158/1078-0432.ccr-06-2309 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004441322
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1158/1078-0432.ccr-11-0120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019815454
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1159/000314980 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008619638
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1200/jco.2003.99.046 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064204075
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1200/jco.2008.19.8721 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042965400
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1200/jco.2009.22.0616 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048915750
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1200/jco.2009.22.3271 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050418707
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1200/jco.2010.30.2729 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017963788
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1212/01.wnl.0000304121.57857.38 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064350042
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1212/wnl.0b013e3181a413be schema:sameAs https://app.dimensions.ai/details/publication/pub.1064354319
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1215/15228517-2008-009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064414329
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1227/01.neu.0000370918.51053.bc schema:sameAs https://app.dimensions.ai/details/publication/pub.1025819952
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1586/14737140.4.2.303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010214744
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1634/theoncologist.2010-0105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001559376
303 rdf:type schema:CreativeWork
304 https://doi.org/10.3109/0284186x.2011.572913 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006425289
305 rdf:type schema:CreativeWork
306 https://doi.org/10.3171/jns.2007.106.4.601 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071102269
307 rdf:type schema:CreativeWork
308 https://www.grid.ac/institutes/grid.413005.3 schema:alternateName Azienda Ospedaliero Universitaria San Giovanni Battista
309 schema:name Division of Neuro-oncology, Department of Neuroscience, University and San Giovanni Battista Hospital, Turin, Italy
310 rdf:type schema:Organization
311 https://www.grid.ac/institutes/grid.417894.7 schema:alternateName Istituto Neurologico Carlo Besta
312 schema:name Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous, System Review Group, Unit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
313 Department of Neurooncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
314 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...